Karydas Daphne — SEC Form 4 filings
SEC reporting owner CIK 1816952. 10 Form 4 filings on record with FilingPulse; latest filed 2026-09-17.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-05-13 to 2026-09-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 5 legs across 4 filings — 24,000 shares, $925,537 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 15.
- Largest priced transaction: sale of 10,115 shares @ $45.81 ($463,351) in Mineralys Therapeutics, Inc., filed 2025-11-13.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Mineralys Therapeutics, Inc. (MLYS) | Director | 7 | — | 5 legs · 24,000 sh · $925,537 | 12 |
| COMPASS Pathways plc (CMPS) | Director | 3 | — | — | 3 |
Form 4 filings — Karydas Daphne
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-17 | 4 | Mineralys Therapeutics, Inc. (MLYS) | Option exercise (M): 3,000 @ $12.02 · Sale (S): 3,000 @ $28.58 · Option exercise (M): 3,000 (derivative) @ $0 | EDGAR |
| 2026-06-17 | 4 | Mineralys Therapeutics, Inc. (MLYS) | Option exercise (M): 3,000 @ $12.02 · Sale (S): 3,000 @ $25 · Option exercise (M): 3,000 (derivative) @ $0 | EDGAR |
| 2026-05-29 | 4 | COMPASS Pathways plc (CMPS) | Grant/award (A): 21,110 (derivative) @ $0 | EDGAR |
| 2026-04-02 | 4 | Mineralys Therapeutics, Inc. (MLYS) | Option exercise (M): 3,000 @ $12.02 · Sale (S): 3,000 @ $25 · Option exercise (M): 3,000 (derivative) @ $0 | EDGAR |
| 2026-02-20 | 4 | Mineralys Therapeutics, Inc. (MLYS) | Grant/award (A): 6,200 @ $0 · Grant/award (A): 8,300 (derivative) @ $0 | EDGAR |
| 2025-11-13 | 4 | Mineralys Therapeutics, Inc. (MLYS) | Option exercise (M): 15,000 @ $10.20 · Sale (S): 10,115 @ $45.81 · Sale (S): 4,885 @ $46.36 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2025-06-13 | 4 | COMPASS Pathways plc (CMPS) | Grant/award (A): 26,000 (derivative) @ $0 | EDGAR |
| 2025-02-24 | 4 | Mineralys Therapeutics, Inc. (MLYS) | Grant/award (A): 32,900 (derivative) @ $0 | EDGAR |
| 2024-05-23 | 4 | Mineralys Therapeutics, Inc. (MLYS) | Grant/award (A): 22,000 (derivative) @ $0 | EDGAR |
| 2024-05-13 | 4 | COMPASS Pathways plc (CMPS) | Grant/award (A): 26,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1816952 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →